Blasting antibodies with lasers provides direct way of measuring their flexibilities

December 17, 2002

A group of scientists at The Scripps Research Institute (TSRI) and San Diego Supercomputer Center at the University of California at San Diego (UCSD) have used a powerful laser in combination with innovative quantum mechanical computations to measure the flexibility of mouse antibodies.

The new technique, described in an upcoming issue of the journal Proceedings of the National Academy of Sciences, is significant because protein flexibility is believed to play an important role in antibody-antigen recognition, one of the fundamental events in the human immune system.

"This is the first time anybody has ever gone into a protein and experimentally measured the frequency of protein vibrations in response to an applied force," says Floyd Romesberg, assistant professor in the Department of Chemistry at The Scripps Research Institute, who led the study.

"Our results show that the motions of the antibody-antigen complexes can range over four orders of magnitude, from tens of femtoseconds to hundreds of picoseconds," says co-author Kim K. Baldridge, Ph.D., director of Integrative Computational Sciences at the San Diego Supercomputer Center and an adjunct professor of Chemistry at UCSD. "This is evidence of a general mechanism of antigen-antibody interactions--which range from rigid to flexible," she adds.

Flexibility of Proteins

Protein flexibility is an important concept in biology because of its role in protein-protein and protein-ligand recognition. One of the longest running debates in molecular recognition is how proteins recognize and bind to other molecules--whether it resembles putting a key into a lock (the lock and key model) or catching a baseball in a catcher's mitt (the induced fit model).

There are lots of ideas about mechanisms of antigen recognition postulated in the literature, but what the debate comes down to is really a question of flexibility. How flexible are proteins?

Unfortunately, flexibility is difficult to characterize experimentally, and there has never been a study like this one to carefully examine the details of antibody recognition of antigen at the molecular level, which involves bond vibrations that ever-so-slightly displace atoms a million times every millionth of a second. Scientists have had a tough time studying these vibrations because the two main techniques that allow them to "look" at proteins--nuclear magnetic resonance (NMR) and X-ray crystallography--cannot be used.

X-ray crystallography provides only average structures, which provide no direct information on a protein's flexibility. NMR can, in principle, be used to measure a protein's flexibility, but in practice is limited to slow timescales, involving large amplitude motions. Moreover, the number of atoms within a molecule the size of an antibody is so large that drawing conclusions from the data is nearly impossible.

Now Romesberg, Baldridge, and their colleagues have developed a way to measure the flexibility of proteins over timescales ranging from femtoseconds to nanoseconds using a combination of spectroscopy and quantum mechanical techniques.

Shaken Not Stirred

For years biochemists have routinely used bench top ultraviolet and visible light spectrometers to measure things like protein concentration or to follow chemical reactions. However, Romesberg's spectrometer is not the kind you might find in any catalog of equipment lying around the lab.

This laser, built by Romesberg and Research Associate Ralph Jimenez, Ph.D., takes up an entire room and emits a burst of photons in a roughly 50-femtosecond pulse--which is billions of times faster than the fastest shutter speed on a good camera. This incredible speed is necessary, because just as a fast shutter speed captures a fast movement on film, a fast laser captures a fast movement within a protein.

"The laser allows us to take 'photographs' of a protein vibrating," says Romesberg.

In their experiments, Romesberg and Jimenez mix human antibodies with dye molecules. When the mixture is blasted with the laser beam, the dye molecules absorb energy from the laser and transmit some of this energy into the antibody.

The only place for the energy to go within the antibody is for it to be absorbed by vibrating bonds within the protein. The electron distribution in these bonds may then change, depending on how much they vibrate. By comparing an excited, "spectra" readout to a normal spectrum, Romesberg and his colleagues can assess how flexible particular parts of a protein are.

This is not always simple. Antibodies are large proteins with lots of vibrating bonds, and molecular motions. Quantum mechanical calculations can help researchers delineate which motions are primary participants in the antibody-antigen recognition process. Baldridge took the results of these computations and provided a visual way to understand the effect of the force on the protein.

The quantum mechanical calculations actually give a depiction of the electrostatic processes that are occurring. Together with the experimental information, this helps complete the puzzle of how various bonds are moving, twisting, and interacting with other atoms in the protein environment.

The lock-and-key model specifies that if the antigen and antibody are not matched up in a rigid, structural way, they will not bind. Romesberg, Baldridge, and their colleagues found this to be true for one of the antibodies they tested. But two of the other antibodies appeared to wiggle a lot to achieve their optimal energetic state.

Antibody recognition, says Romesberg, may not be a simple, lock-and-key mechanism, but one in which the keys and the locks are vibrating and changing their shape as they come together in solution.
-end-
The article, "Flexibility and Molecular Recognition in the Immune System" was authored by Ralph Jimenez, Georgina Salazar, Kim K. Baldridge, and Floyd E. Romesberg, and appears in the online edition of the journal Proceedings of the National Academy of Sciences the week of December 16, 2002. The article will appear in print early next year.

This work was supported by The Skaggs Institute for Chemical Biology, the National Science Foundation, and the National Institutes of Health.

Scripps Research Institute

Related Antibodies Articles from Brightsurf:

Scientist develops new way to test for COVID-19 antibodies
New research details how a cell-free test rapidly detects COVID-19 neutralizing antibodies and could aid in vaccine testing and drug discovery efforts.

Mussels connect antibodies to treat cancer
POSTECH research team develops innovative local anticancer immunotherapy technology using mussel protein.

For an effective COVID vaccine, look beyond antibodies to T-cells
Most vaccine developers are aiming solely for a robust antibody response against the SARS-CoV-2 virus, despite evidence that antibodies are not the body's primary protective response to infection by coronaviruses, says Marc Hellerstein of UC Berkeley.

Children can have COVID-19 antibodies and virus in their system simultaneously
With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

The behavior of therapeutic antibodies in immunotherapy
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells.

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites
This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.

Neutralizing antibodies in the battle against COVID-19
An important line of defense against SARS-CoV-2 is the formation of neutralizing antibodies.

Three new studies identify neutralizing antibodies against SARS-CoV-2
A trio of papers describes several newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV infection.

More effective human antibodies possible with chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories.

Read More: Antibodies News and Antibodies Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.